Brendan OConnell - 01 Jun 2026 Form 4 Insider Report for MDxHealth SA (MDXH)

Reporting relationship: VP, Finance and Accounting
Issuer ticker: MDXH
Reported as of: 01 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2026, 17:30:13 UTC
Prior SEC filing: 28 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark Busch, as attorney-in-fact for Brendan O'Connell

Key filing fact

Brendan OConnell filed Form 4 for MDxHealth SA (MDXH) on 03 Jun 2026.

Key facts

This page summarizes Brendan OConnell's Form 4 filing for MDxHealth SA (MDXH).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 03 Jun 2026, 17:30.

Change

Previous filing in this sequence was filed on 28 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002136588 Primary reporting owner

OConnell Brendan

Relationship: VP, Finance and Accounting
Address: CAP BUSINESS CENTER, ZONE INDUSTRIELLE DES HAUTS-SARTS, HERSTAL, BELGIUM
Signature: /s/ Mark Busch, as attorney-in-fact for Brendan O'Connell
Signature date: 03 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MDXH transaction Derivative

Share Option

Award

Transaction value
Shares: +35,000
Change %
Price: $0.000000^*
Shares after: 35,000
Date: 01 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 35,000
Exercise price: $0.7600
Footnotes: F1

MDXH transaction Derivative

Share Option

Award

Transaction value
Shares: +65,000
Change %
Price: $0.000000^*
Shares after: 65,000
Date: 01 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 65,000
Exercise price: $0.7600
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026. The options vest upon the achievement of certain Company performance criteria evaluated by the Board of Directors at the end of the relevant performance periods.

Footnote F2

Represents options to purchase ordinary shares at a price per share of $0.76 granted on June 1, 2026 . The options vest in three equal installments on each of the first three anniversaries of the date of grant.